Company research / CHUC

Charlie's Holdings, Inc. (CHUC)

CIK 0001134765 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Charlie's Holdings, Inc. reported revenue of $20.92M. Revenue grew 169.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

27.0%
Gross margin
-10.4%
Operating margin
21.5%
Net margin
131.4%
Return on year-end equity
169.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-04

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenuen/a$20.92M$7.76M$16.25M$26.42M$21.50M$16.69M$22.74M$20.84M$3.82M$2.58M
Cost of Revenue$19.10M$15.26M$4.89Mn/an/an/a$7.48M$10.07M$8.52Mn/an/a
Gross Profit$7.08M$5.66M$2.88Mn/an/an/an/an/a$718.6K$771.2K$321.9K
R&D Expensen/an/an/a$169.0K$804.0K$24.0K$3.38M$1.10M$0n/an/a
Operating Incomen/a-$2.17M-$3.30M-$2.20M-$1.80M$565.0K-$6.77M-$5.76M$7.20M-$14.44M-$8.29M
Depreciation & Amortization$25.0K$39.0K$104.0K$154.0K$296.0K$210.0K$181.0K$73.0K$18.0Kn/an/a
EBITDAn/a-$2.13M-$3.20M-$2.05M-$1.51M$775.0K-$6.59M-$5.69M$7.22Mn/an/a
Net Income-$1.96M$4.50M-$4.16M-$2.09M-$1.59M$4.81M-$7.19M-$2.15M$7.20M-$12.45M-$5.45M
EPS (Diluted)n/a$0.02-$0.02-$0.01-$0.01$0.01-$0.04$0.00$0.00n/an/a
Total Assets$12.79M$11.56M$3.94M$5.77M$7.06M$9.25M$6.53M$7.85M$2.19M$4.87M$4.94M
Total Liabilities$9.66M$8.14M$5.72M$5.88M$5.36M$6.12M$12.52M$8.39M$1.40M$10.26M$7.16M
Long-Term Debtn/an/a$2.16M$2.46M$1.45M$150.0Kn/an/an/an/an/a
Shareholders' Equity$3.13M$3.42M-$1.78M-$107.0K$1.70M$3.13M-$6.00M-$547.0K$791.0K-$5.39M-$2.22M
Cash & Equivalentsn/an/an/an/an/an/an/an/a$43.2K$76.5K$15.3K
Operating Cash Flow-$4.20M-$5.78M-$1.62M-$783.0K-$1.72M-$1.35M-$3.27M-$2.04M$7.62M-$6.43M-$5.67M
Capital Expendituresn/a$23.0K$0$0$189.0K$110.0K$169.0K$571.0K$16.0K$0$11.8K
Free Cash Flown/a-$5.80M-$1.62M-$783.0K-$1.91M-$1.46M-$3.44M-$2.61M$7.60M-$6.43M-$5.68M
Dividends Paidn/an/an/an/a$0$883.0K$0$18.41M$7.95Mn/an/a
Shares Outstanding280.55M270.65M257.29M228.54M219.16M210.89M189.91M18.97B245.68M218.15M119.40M
Weighted Average Diluted Sharesn/a278.54M234.80M216.05M212.27M237.69M189.84M10.65B14.10Bn/an/a
EPS (Basic)n/a$0.02-$0.02-$0.01-$0.01$0.02-$0.04$0.00$0.05n/an/a